| MeSH term | MeSH ID | Detail |
|---|---|---|
| Obesity | D009765 | 29 associated lipids |
| Liver Diseases | D008107 | 31 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Neurodegenerative Diseases | D019636 | 32 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Neurotoxicity Syndromes | D020258 | 34 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Epilepsy | D004827 | 35 associated lipids |
| Liver Cirrhosis, Experimental | D008106 | 36 associated lipids |
(r)-3-hydroxybutanoic acid
(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with (r)-3-hydroxybutanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Matković M et al. | Synthesis of novel adamantyl and homoadamantyl-substituted β-hydroxybutyric acids. | 2013 | Mol. Divers. | pmid:24043584 |
| Zebeli Q et al. | Intermittently-induced endotoxaemia has no effect on post-challenge plasma metabolites, but increases body temperature and cortisol concentrations in periparturient dairy cows. | 2013 | Res. Vet. Sci. | pmid:23911054 |
| Yuan K et al. | TNFα altered inflammatory responses, impaired health and productivity, but did not affect glucose or lipid metabolism in early-lactation dairy cows. | 2013 | PLoS ONE | pmid:24260367 |
| Hornig KJ et al. | Evaluation of a point-of-care glucose and β-hydroxybutyrate meter operated in various environmental conditions in prepartum and postpartum sheep. | 2013 | Am. J. Vet. Res. | pmid:23879842 |
| Fanos V et al. | Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. | 2013 | Early Hum. Dev. | pmid:23809353 |
| Ospina PA et al. | Using nonesterified fatty acids and β-hydroxybutyrate concentrations during the transition period for herd-level monitoring of increased risk of disease and decreased reproductive and milking performance. | 2013 | Vet. Clin. North Am. Food Anim. Pract. | pmid:23809897 |
| El-Deeb WM | Clinicobiochemical investigations of gangrenous mastitis in does: immunological responses and oxidative stress biomarkers. | 2013 | J Zhejiang Univ Sci B | pmid:23303629 |
| Xu J et al. | Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition. | 2013 | Appl. Biochem. Biotechnol. | pmid:23306893 |
| Hughes TE et al. | Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. | 2013 | Obesity (Silver Spring) | pmid:23512440 |
| Haviland JA et al. | NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. | 2013 | Obesity (Silver Spring) | pmid:23512955 |